Synaptic plasticity is mediated by changes in the surface expression of AMPA receptors (AMPARs). Stargazin and related transmembrane AMPAR regulatory proteins have emerged as the principal regulators of AMPAR surface expression. Here, we show in heterologous cells and primary neurons that stargazin is physiologically S-nitrosylated, resulting in increased surface expression. Snitrosylation of stargazin increases binding to the AMPAR subunit GluR1, causing increased surface expression of the AMPAR. NMDAR stimulation, well known to activate neuronal nitric oxide synthase, increases both nitrosylation of stargazin and its binding to AMPAR. Thus, S-nitrosylation of stargazin is a physiologic regulator of AMPAR surface expression.
G
lutamate, the principal excitatory neurotransmitter in the brain, acts predominantly through its AMPA and NMDA receptor subtypes. Synaptic plasticity in the brain is determined to a major extent by variations in the surface expression of AMPA receptors (AMPARs) (1, 2) . This process is modulated by a number of cytosolic proteins (3) . Stargazin, the founding member of the transmembrane AMPAR regulatory protein (TARP) family, is unique in its nature and extent of interaction with AMPARs. Unlike other regulators of AMPAR surface expression, stargazin is a small tetraspanning membrane protein that is an auxiliary subunit of all subtypes of AMPARs, and interacts with a large proportion of them. Therefore, it appears to be a principal determinant of AMPAR surface expression. Stargazin is most abundantly expressed in the granule cells of the cerebellum, where unlike other brain regions, it is the sole expressed TARP isoform. It is also expressed at high levels in the cortex (3) (4) (5) (6) . The regulation of stargazin surface expression and its impact on AMPAR surface expression remain largely unknown. NMDA neurotransmission influences synaptic plasticity (3) . NMDA receptor activation increases phosphorylation of AMPARs (3, 7) , and stargazin (8) , but mechanisms by which NMDA neurotransmission regulates stargazin mediated-AMPAR surface expression remain largely unclear.
Signaling by NMDA neurotransmission in many instances is mediated by nitric oxide (NO) (9, 10) . NO, in turn, signals by stimulating cGMP formation or by nitrosylating target proteins (11, 12) . NO impacts AMPAR trafficking. For example, nitrosylation of N-ethylmaleimide sensitive factor (NSF) regulates surface expression of the AMPAR subtype GluR2 (13) . However, NSF only regulates the GluR2 subtype of AMPARs (3) .
Because stargazin mediates surface expression of all AMPARs, and appears to be the principal determinant of their surface expression, we wondered whether it might be Snitrosylated. In the present study, we demonstrate that stargazin is physiologically nitrosylated by NO under basal conditions. This process increases the interaction of the two proteins and facilitates surface expression of stargazin and the AMPAR subunit GluR1. Also, we show that NMDAR activation both increases nitrosylation of stargazin and its interaction with GluR1.
Results
In HEK 293 cells overexpressing stargazin, the NO donor cysteine-NO elicits pronounced nitrosylation of stargazin ( Fig. 1  A and B) . Stargazin possesses six cysteines, four associated with the extracellular domain of the receptor and one in the transmembrane region, whereas only cysteine-302 occurs intracellularly in the C-terminal tail, presumably accessible to NO formed inside cells. Nitrosylation of stargazin containing a cysteine to serine mutation at this position (C302S) is profoundly reduced compared with the WT protein ( Fig. 1 A and B) .
NO donors, including cysteine-NO, might be nonphysiologic, because they lack the spatial resolution provided by enzymatically generated intracellular NO. Therefore, we examined the influence on stargazin of NO produced intracellularly. In human embryonic kidney (HEK)293 cells constitutively expressing neuronal NO synthase (HEK-nNOS), stargazin, but not stargazin-C302S, is nitrosylated ( Fig. 1 C and D) .
To explore the nitrosylation of stargazin in the brain, we used primary cultures of neurons. In cerebellar granule cell neurons and cortical neurons, we observe robust nitrosylation of stargazin, which is markedly reduced in preparations from nNOS deleted mice ( Fig. 1 E-H) .
To examine whether stargazin nitrosylation affects its trafficking, we monitored the surface expression of stargazin in HEK293 cells overexpressing the protein (Fig. 2 A and B) . Treatment with cysteine-NO elicits robust surface expression of stargazin, which is abolished with stargazin-C302S. Also, HEKnNOS cells display much greater surface levels of stargazin than WT HEK cells ( Fig. 2 C and D) . The surface expression of stargazin in these cells is mediated by S-nitrosylation of C302 in an nNOS activity-dependent manner. Thus, stargazin surface expression is abolished by the nNOS inhibitor VNIO, and is substantially reduced for stargazin-C302S ( Fig. 2 E and F) . Stargazin trafficking is also regulated by nNOS in the brain. Thus, in cerebellar granule cells, surface expression of stargazin is profoundly reduced in preparations from nNOS deleted mice or after treatment with the NOS inhibitor L-NAME ( Fig. 2  G and H) .
Because stargazin is a principal determinant of AMPAR surface expression, we examined the effect of S-nitrosylated stargazin on GluR1 surface expression. In cells expressing both GluR1 and stargazin, the surface expression of GluR1 in HEKnNOS cells is increased relative to HEK cells that lack nNOS (Fig. 3 A and B) . To determine any direct effects of NO on GluR1 surface expression, we used HEK-nNOS cells overexpressing either GluR1 alone or both GluR1 and stargazin. In the absence of stargazin, surface levels of GluR1 are not influenced by the nNOS inhibitor VNIO. Overexpression of stargazin markedly augments surface GluR1 levels, which are profoundly reduced by VNIO (Fig. 3 C and D) . Because NOS inhibition has no effect on GluR1 trafficking in the absence of stargazin, we conclude that NO regulates GluR1 disposition by influencing the nitrosylation of stargazin. This conclusion is supported by experiments showing that surface GluR1 levels in HEK-nNOS cells are markedly reduced in cells expressing stargazin-C302S relative to WT stargazin ( Fig. 3 E and F) . The effect of S-nitrosylated stargazin on GluR1 surface expression is physiologic as evidenced by the decreased surface expression of GluR1 in granule cell neurons obtained from nNOS KO animals relative to WT ( Fig. 3 G and H) , and the decreased surface expression of GluR1 in WT neurons after treatment with the NOS inhibitor, L-NAME, relative to untreated controls ( Fig. 3 
I and J).
By what molecular mechanism might S-nitrosylation of stargazin influence GluR1 surface expression? Binding of stargazin to GluR1 is an obligate requirement of surface expression (4, (14) (15) (16) (17) . Thus, GluR1 surface expression is decreased in the presence of stargazin mutants with diminished AMPAR binding (14, 17) . The binding of GluR1 to stargazin is significantly reduced in HEK-nNOS cells either on inhibition of nNOS activity or expression of C302S-stargazin. (Fig. 4 A and B) . This finding implies that S-nitrosylation of stargazin at cysteine-302 increases GluR1 surface expression by stimulating the binding of stargazin to GluR1. The effect of NO on binding of stargazin to GluR1 is physiologic as evidenced by decreased binding of GluR1 to stargazin in granule cell neurons obtained from nNOS KO animals (Fig. 4 C and D) , and decreased binding of stargazin to GluR1 in cortical neurons treated with the NOS inhibitor, L-NAME (Fig. 4 E and F) .
NMDA receptor stimulation increases intracellular NO by activating nNOS (9, 10) . Therefore, we wondered whether NMDA receptor stimulation influences AMPARs by increasing nitrosylation of stargazin. Accordingly, we examined the effect of NMDA on nitrosylation of stargazin. In granule cells, brief treatment with low concentrations of NMDA elicits a dramatic increase in stargazin nitrosylation (Fig. 5 A and B) . NMDA treatment also markedly increases stargazin-GluR1 binding with the increase diminished in nNOS deleted preparations or after treatment with the NOS inhibitor L-NAME (Fig. 5 C and D) .
Discussion
In summary, we have elucidated a signaling cascade whereby cellular NO under basal conditions nitrosylates stargazin at cysteine-302 that in turn augments its binding to GluR1 to enhance surface expression of the receptor. NMDAR stimulation increases nitrosylation of stargazin and increases its interaction with GluR1 in an NO-dependent manner. Mediation of NMDA transmission via NO is well established (9) . Although we directly demonstrate NMDA-mediated increase of stargazin nitrosylation, and stargazin-GluR1 binding, we have not examined the influence of NMDA on GluR1 trafficking for the following reason: The preponderance of AMPARs are localized extrasynaptically and are internalized in response to NMDA transmission (3, 18) , whereas only a small synaptic pool of AMPARs is thought to be externalized in response to NMDA (3, 18, 19) . For these technical reasons, it would not be biochemically feasible to monitor potential stimulation of the surface expression of synaptic GluR1 in response to NMDA.
The turnover of NO groups on proteins has been extensively studied (12) . Nitrosylation occurs very rapidly, and denitrosylation can be comparably rapid whether spontaneous or via a denitrosylating enzyme. Accordingly, in most instances, the time course of these processes might not be rate limiting for the overall events that comprise NMDAR activation, stimulation of nNOS to generate NO, nitrosylation of stargazin, and its translocation along with GluR1. However, in some cases, both basal and stimulated denitrosylation take place over varied time scales (20) (21) (22) (23) (24) . In the case of stargazin-mediated GluR1 surface expression, nitrosylation of stargazin does not have an obligate role in trafficking; instead, it exerts a regulatory influence.
NO influences other proteins that regulate AMPA receptors. Serulle et al. (25) reported that cGMP-dependent protein kinase II increased AMPA receptor trafficking in hippocampal cultures in a cGMP-dependent manner with an indirect role for NO. The extent of regulation of AMPARs by cGMP-dependent protein kinase II is unclear. Nitrosylation of NSF enhances its capacity to augment surface expression of GluR2 receptors (13) . However, NSF only binds to GluR2 (16, 26) . By contrast, stargazin interacts with all subtypes of AMPARs and impacts a large fraction of these receptor subtypes (5) . It was recently shown that a new family of AMPAR auxiliary subunits, named cornichons (CNIH-1 and CNIH-2), regulate a large fraction of AMPAR trafficking and function much like TARPs (27) (28) (29) . The cornichon proteins are absent in granule cells of the cerebellum (28) . Thus, it is likely that physiologic influences of NMDA/NO transmission on cerebellar AMPAR trafficking in granule cells are predominantly mediated by the nitrosylation of stargazin reported here. Cerebellar granule cells contain the highest density of the brain of nNOS and stargazin in the absence of any other TARP family member. Thus, the pathway described here appears to be the predominant and possible sole form of NO/TARP/AMPA-R signaling in these cells. How do nNOS containing neurons interface with stargazincontaining cells? Although nNOS neurons comprise a minor population of neuronal cells, their processes ramify so extensively that they may impact virtually all other cells in the brain (30) . The original model for NO acting as a neurotransmitter assumed that NO released from terminals diffuses into this large population of adjacent cells where it interacts with diverse targets, activating soluble guanylyl cyclase or nitrosylating selected proteins. Alternatively, the NO that nitrosylates target proteins is conveyed intracellularly via direct binding of a NOS isoform or via an intermediate scaffolding protein such as CAPON (31) . In the latter case, nNOS would interface only with stargazin in nNOS neurons, which in turn can influence many other cells. In the cerebellum, granule cells, which are very abundant, contain nNOS so that interface with stargazin would be universal even if only nNOS neurons were involved.
AMPAR trafficking underlies much of the synaptic plasticity that has been implicated in long-term depression and long-term potentiation as models of learning and memory (2, 3) . Abundant literature supports a role for NO in these processes (10, 32, 33) . Our findings suggest that nitrosylation of stargazin is a nodal point in the regulation of these forms of synaptic plasticity in the context of the granule cells of the cerebellum and cortex.
Methods
Cell Culture. HEK293 and HEK-nNOS cells were cultured in DMEM with FBS (10%), pencillin-streptomycin (2%), L-glutamine (2 mM) and tylosin (8 g/mL) (Sigma-Aldrich). Dissociated granule cells were prepared from mouse cerebellum as described earlier (34) . Dissociated cortical neurons were prepared from embryonic day 18 -19 mouse brains in neurobasal media with B27 supplement (GIBCO, BRL).
Plasmids and Transfections. The pRK5 rat GluR1 and pcDNA3.1ϩ human stargazin were used in all experiments. The single cysteine mutation of stargazin (stargazin C302S) was made by using standard protocols for Pfu Turbo DNA polymerase (Stratagene). GluR1 (1.5 g) and stargazin (1.0 g) plasmids were transfected into HEK cells by using Polyfect (Qiagen) following manufacturer's instructions. For all experiments, transfected cells were lysed within 24 h.
Antibodies and Reagents.
Rabbit polyclonal anti-stargazin antibody was prepared in the Huganir lab, and obtained from Chemicon/Millipore. Mouse monoclonal anti-GluR1 and rabbit polyclonal anti-GluR1 were prepared in the Huganir lab. The plasmid for GST-C-terminal fragment of stargazin was obtained from Susumu Tomita (Yale University, New Haven, CT).
Biotin-Switch Assay. Cell extracts were analyzed by the biotin-switch assay as described before with modifications (11) . Briefly, cells were extracted in HEN buffer (250 mM Hepes/1 mM EDTA/0.1 mM Neocuproine, pH 7.7) containing Triton X-100 (1%). Extracts were treated with methyl methanethiosulfonate (Sigma-Aldrich) and SDS (1%) at 50°C for 20 min. Proteins were precipitated with acetone, and the precipitate was labeled with biotin-HPDP (0.2 mM) (Pierce) with or without ascorbate (50 mM) for 90 min at room temperature. Proteins were reprecipitated with acetone, and the precipitate was incubated with anti-stargazin antibody (Chemicon/Millipore). The immune complex was eluted with the GST-tagged C-terminal fragment of stargazin (immunizing antigen), and the eluate was incubated with glutathione-Sepharose beads to remove the GST-fragments. The biotinylated proteins in the supernatant were purified by using neutravidin beads (Pierce), separated by SDS/PAGE, and analyzed by Western blotting.
Surface-Biotinylation Assay. Neuronal cells and HEK cells were incubated with aCSF [sodium chloride (124 mM), potassium chloride (3 mM), calcium chloride (2 mM), magnesium chloride (2 mM), Hepes (10 mM), D-glucose (10 mM), pH 7.34 -7.36] and Dulbecco's PBS, respectively, before analysis with surfacebiotinylation assay, which was performed as before with modifications (35) . Briefly, cells were incubated with sulfo-NHS-biotin (1.5 mg/mL) (Pierce) at 4°C for 20 min. Cells were then washed to remove unbound biotin, followed by extraction in lysis buffer [potassium phosphate (50 mM), sodium chloride (150 mM), pH 7.4, Triton X-100 (1%)] for 1 h at 4°C. The biotinylated proteins were purified by using neutravidin beads, separated by SDS/PAGE, and analyzed by Western blotting.
Immunoprecipitation. Both neuronal and HEK cells were extracted in lysis buffer [potassium phosphate (50 mM), sodium chloride (150 mM) [pH 7.4], Triton X-100 (0.5%), desferroxamine (0.1 mM), protein and phosphatase inhibitor cocktails (Sigma)] for 1 h at 4°C in the dark. The extracts were incubated with anti-stargazin antibody (1-2 g/mg protein) overnight at 4°C in the dark. The immune-complex was pulled down with protein-A beads, separated by SDS/PAGE, and analyzed by Western blotting.
Statistical Analysis.
All experiments were performed a minimum of three times. Western blottings were developed by using enhanced chemiluminescence, X-ray films were scanned densitometrically, and the images were quantified using NIH-Image J software. Data are expressed as mean Ϯ SEM from the indicated number of experiments. Statistical significance was determined by using an unpaired Student's t test, and the P value is noted relative to appropriate controls in the figure legend. 
